The Journal covers clinical therapeutics of Sickle Cell Anemia regarding hydroxyurea’ treatment sections such the Clinical Problem, Pathophysiology and Effect of Therapy (click picture to enlarge), Clinical evidence, Hydroxyurea Clinical Use, Adverse Effects of Hydroxyurea, Peripheral-Blood Thresholds for Adjustment of the Dose of Hydroxyurea, and Areas of Uncertainty in the Hydroxyurea treatment.
Archives for anemia
Anemia and Its Association with Chronic Kidney Disease
Anemia is a common complication of chronic kidney disease (CKD), develops early, and worsens as CKD progresses. The Renal Anemia Management Period (RAMP) promoted an early identi?cation and treatment of CKD-related anemia to prevent serious consequences.
The article below described association between Anemia and Chronic Kidney Disease. CKD arises as a consequence of diabetes mellitus, [...]
Sickle Cell Anemia, Treatment and Guideline
Sickle Cell Anemia is an inherited disorder in which red blood cells contain an abnormal form of hemoglobin, a protein that carries oxygen. The abnormal form of hemoglobin causes the red cells to become sickle- or crescent-shaped. The misshapen cells may clog blood vessels, preventing oxygen from reaching tissues and leading to pain, blood [...]
Microcytic Hypochromic Anemia in Association with Thalasemia, a Genotype Approach
Molecular genotyping provides a rapid and reliable method for identification of common, rare and unknown a- and b- gene mutations, which help to diagnose unexplained microcytosis and thus prevent unnecessary iron supplementation, according to one of Indian Journal of Medical Sciences published on March.
The aims of this study, accordingly, was to evaluate the frequency of [...]
